1.
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
by Wu, Hao
Nature Medicine, 2017, Vol.23 (7), p.850-858
2.
The antidiabetic gutsy role of metformin uncovered?
by Burcelin, Rémy
Gut, 2014, Vol.63 (5), p.706-707
3.
Estrogens Protect against High-Fat Diet-Induced Insulin Resistance and Glucose Intolerance in Mice
by Riant, Elodie
Endocrinology (Philadelphia), 2009, Vol.150 (5), p.2109-2117
4.
Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice
by Blasco-Baque, Vincent
Diabetologia, 2017, Vol.60 (4), p.690-700
5.
Europe has to step up its efforts to produce innovative and safe diabetes technology
by Cnop, Miriam
Diabetologia, 2017, Vol.60 (12), p.2532-2533
6.
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
by Hoyles, Lesley
Nature Medicine, 2018, Vol.24 (7), p.1070-1080
7.
Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
by Waget, Aurélie
Endocrinology (Philadelphia), 2011, Vol.152 (8), p.3018-3029
8.
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept
by Amar, J
Diabetologia, 2011, Vol.54 (12), p.3055-3061
9.
Intracerebroventricular Infusion of Glucose, Insulin, and the Adenosine Monophosphate-Activated Kinase Activator, 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside, Controls Musc...
by Perrin, Christophe
Endocrinology (Philadelphia), 2004, Vol.145 (9), p.4025-4033
10.
Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure
by Knauf, Claude
Endocrinology (Philadelphia), 2008, Vol.149 (10), p.4768-4777
11.
Changes in Lipoprotein Kinetics Associated With Type 2 Diabetes Affect the Distribution of Lipopolysaccharides Among Lipoproteins
by Vergès, Bruno
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (7), p.E1245-E1253
12.
n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet
by Kuda, O
Diabetologia, 2009, Vol.52 (5), p.941-951
13.
Liver Adenosine Monophosphate-Activated Kinase-α2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin
by Andreelli, Fabrizio
Endocrinology (Philadelphia), 2006, Vol.147 (5), p.2432-2441
14.
Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice
by Clerc, Pascal
Endocrinology (Philadelphia), 2007, Vol.148 (3), p.1039-1049
15.
Peroxisome Proliferator-Activated Receptor-α-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain
by Knauf, Claude
Endocrinology (Philadelphia), 2006, Vol.147 (9), p.4067-4078
16.
Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
by Hoyles, Lesley
Nature Medicine, 2018, Vol.24 (10), p.1628-1628
17.
An Adiponectin-Like Molecule with Antidiabetic Properties
by Sulpice, Thierry
Endocrinology (Philadelphia), 2009, Vol.150 (10), p.4493-4501
18.
Gonadotropin-Releasing Hormone Secretion from Hypothalamic Neurons: Stimulation by Insulin and Potentiation by Leptin
by Burcelin, Rémy
Endocrinology (Philadelphia), 2003, Vol.144 (10), p.4484-4491
19.
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
by Serino, Matteo
Gut, 2012, Vol.61 (4), p.543-553
20.
Pancreatic Islet Adaptation to Fasting Is Dependent on Peroxisome Proliferator-Activated Receptor α Transcriptional Up-Regulation of Fatty Acid Oxidation
by Gremlich, Sandrine
Endocrinology (Philadelphia), 2005, Vol.146 (1), p.375-382
